8,517 articles
Peter T. Lansbury
Peter T. Lansbury, also known as Peter Lansbury, is an American chemist turned neurodegeneration researcher, professor of neurology at Harvard Medical School, and founder of Link Medicine.
Peter T. Macklem
Peter T. Macklem (1931–2011) was a Canadian respiratory physician-scientist at McGill University in Montreal, known for work on small airways disease and respiratory muscle fatigue.
Peter Tontonoz
Peter Tontonoz is an American physician-scientist and Distinguished Professor at UCLA who studies cholesterol and lipid metabolism, known for the LXR, PPAR, IDOL, and Aster protein discoveries.
Peter Tugwell
Peter Tugwell is a Canadian rheumatologist and clinical epidemiologist at the University of Ottawa, known for rheumatoid arthritis trials, co-founding the Cochrane Collaboration, and health equity in evidence synthesis.
Peter Tyrer
Peter Tyrer is a British community psychiatrist, Emeritus Professor at Imperial College London, who chaired the WHO group revising personality disorder classification for ICD-11 and developed nidotherapy.
Peter Valent
Peter Valent is an Austrian hematologist and physician-scientist at the Medical University of Vienna whose work on mastocytosis underlies the WHO classification of mast cell diseases.
Peter W. Gething
Peter W. Gething is an Australian-based epidemiologist and geospatial modeller of malaria who co-heads the Malaria Atlas Project and is a professor at Curtin University and The Kids Research Institute Australia in Perth.
Peter W. Lampert
Peter W. Lampert (1929–1986) was a German-born American neuropathologist who chaired pathology at UCSD from 1979 until his death, using electron microscopy to study demyelination and viral disease.
Peter W. Stacpoole
Peter W. Stacpoole is a physician-scientist and professor at the University of Florida who has researched dichloroacetate since 1969, leading trials in lactic acidosis and mitochondrial disease.
Peter W.F. Wilson
Peter W.F. Wilson is an American cardiologist and cardiovascular epidemiologist at Emory University whose Framingham work produced the most widely validated heart disease risk prediction rule.
Peter Zimetbaum
Peter J. Zimetbaum is an American cardiac electrophysiologist who directs clinical cardiology at Beth Israel Deaconess Medical Center and is the Richard and Susan Smith Professor of Cardiology at Harvard Medical School.
Petter Brodin
Petter Brodin (born 1982) is a Swedish pediatric immunologist, professor of pediatric immunology at Karolinska Institutet and Garfield Weston Chair of Neonatology at Imperial College London.
Peyton Rous
Francis Peyton Rous was an American cancer virologist who discovered the first tumor-inducing virus, Rous sarcoma virus, in chickens in 1911, winning the 1966 Nobel Prize 55 years later.
Phạm Ngọc Thạch
Phạm Ngọc Thạch (1909–1968) was a Vietnamese physician, tuberculosis specialist, and diplomat who served twice as Minister of Health of North Vietnam and developed a tuberculosis vaccine in 1950.
Phil Gold
Phil Gold, born in Montreal in 1936, is a Canadian physician-scientist who co-discovered the tumor marker CEA in 1965, the basis of a widely used cancer blood test.
Phil Skolnick
Phil Skolnick is a neuroscientist and pharmacologist known for benzodiazepine research, the NMDA receptor hypothesis of depression, and intranasal naloxone; he directed NIDA's medications-development division from 2010 to 2017.
Philip A. Pizzo
Philip A. Pizzo, also known as Philip Pizzo, is an American pediatric oncologist known for defining fever management in children with cancer and for leading Stanford's medical school.
Philip A. Poole‐Wilson
Philip A. Poole-Wilson (1943–2009) was a British cardiologist and British Heart Foundation professor at Imperial College London who chaired the COMET trial and helped make beta-blockers standard in heart failure.
Philip A. Wolf
Philip A. Wolf is an American neurologist and epidemiologist who joined the Framingham Heart Study in 1967 as its first neurologist and served as principal investigator from 1989 to 2014.
Philip Bejon
Philip Bejon is a clinician scientist and Oxford professor of tropical medicine known for malaria vaccine trials, including RTS,S, and spatial epidemiology of malaria in coastal Kenya.
Philip C. Hopewell
Philip C. Hopewell is an American physician-scientist at the University of California, San Francisco, who has led tuberculosis treatment, research, and international control efforts since 1973.
Philip C. Wong
Philip C. Wong is a professor of pathology and neuroscience at Johns Hopkins School of Medicine whose laboratory studies TDP-43 in Alzheimer's disease and ALS-FTD, including a 2024 presymptomatic fluid biomarker.
Philip Cole
Philip Cole is an American epidemiologist at Harvard whose 1971 study established smoking as a cause of bladder cancer and who later argued for tobacco harm reduction.
Philip D. Darney
Philip D. Darney, born 1943, is an American physician-scientist in contraception and reproductive health, a UCSF distinguished professor emeritus and founder of the Bixby Center.
Philip E. Cryer
Philip E. Cryer (1940–2024) was an American endocrinologist at Washington University in St. Louis whose research on glucose counterregulation led him to discover hypoglycemia-associated autonomic failure, also called Cryer Syndrome.
Philip F. Halloran
Philip F. Halloran is a Canadian transplant immunologist and nephrologist at the University of Alberta, known for discovering antibody-mediated rejection and creating the MMDx molecular biopsy system.
Philip Felig
Philip Felig was an American endocrinologist who spent fourteen years as a Yale professor of medicine, established the glucose-alanine cycle, led the Sandoz Research Institute, and died in 2020.
Philip Greenland
Philip Greenland is an American cardiologist and epidemiologist, the Harry W. Dingman Professor of Cardiology at Northwestern University, known for coronary artery calcium scoring for heart disease risk prediction.
Philip H. Henneman
Philip H. Henneman was an American endocrinologist who researched kidney stones and metabolic bone disease, best known for establishing urinary hydroxyproline as a marker of bone collagen turnover in 1963.
Philip J. Barter
Philip J. Barter was an Australian cardiovascular researcher specializing in HDL cholesterol and CETP, who chaired the ILLUMINATE trial of torcetrapib and won the Anitschkow Prize in 2011.